Literature DB >> 25993394

Quantification of neurovascular protection following repetitive hypoxic preconditioning and transient middle cerebral artery occlusion in mice.

Katherine Poinsatte1, Uma Maheswari Selvaraj1, Sterling B Ortega1, Erik J Plautz1, Xiangmei Kong1, Jeffrey M Gidday2, Ann M Stowe3.   

Abstract

Experimental animal models of stroke are invaluable tools for understanding stroke pathology and developing more effective treatment strategies. A 2 week protocol for repetitive hypoxic preconditioning (RHP) induces long-term protection against central nervous system (CNS) injury in a mouse model of focal ischemic stroke. RHP consists of 9 stochastic exposures to hypoxia that vary in both duration (2 or 4 hr) and intensity (8% and 11% O2). RHP reduces infarct volumes, blood-brain barrier (BBB) disruption, and the post-stroke inflammatory response for weeks following the last exposure to hypoxia, suggesting a long-term induction of an endogenous CNS-protective phenotype. The methodology for the dual quantification of infarct volume and BBB disruption is effective in assessing neurovascular protection in mice with RHP or other putative neuroprotectants. Adult male Swiss Webster mice were preconditioned by RHP or duration-equivalent exposures to 21% O2 (i.e. room air). A 60 min transient middle cerebral artery occlusion (tMCAo) was induced 2 weeks following the last hypoxic exposure. Both the occlusion and reperfusion were confirmed by transcranial laser Doppler flowmetry. Twenty-two hr after reperfusion, Evans Blue (EB) was intravenously administered through a tail vein injection. 2 hr later, animals were sacrificed by isoflurane overdose and brain sections were stained with 2,3,5- triphenyltetrazolium chloride (TTC). Infarcts volumes were then quantified. Next, EB was extracted from the tissue over 48 hr to determine BBB disruption after tMCAo. In summary, RHP is a simple protocol that can be replicated, with minimal cost, to induce long-term endogenous neurovascular protection from stroke injury in mice, with the translational potential for other CNS-based and systemic pro-inflammatory disease states.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25993394      PMCID: PMC4541629          DOI: 10.3791/52675

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  45 in total

1.  Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains.

Authors:  A Majid; Y Y He; J M Gidday; S S Kaplan; E R Gonzales; T S Park; J D Fenstermacher; L Wei; D W Choi; C Y Hsu
Journal:  Stroke       Date:  2000-11       Impact factor: 7.914

2.  Repetitive hypoxia extends endogenous neurovascular protection for stroke.

Authors:  Ann M Stowe; Tamer Altay; Angela B Freie; Jeffrey M Gidday
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

3.  Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism?

Authors:  Krisztian J Kapinya; Konstantin Prass; Ulrich Dirnagl
Journal:  Neuroreport       Date:  2002-08-07       Impact factor: 1.837

4.  The middle cerebral artery occlusion model of transient focal cerebral ischemia.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Methods Mol Biol       Date:  2014

5.  Direct experimental occlusion of the distal middle cerebral artery induces high reproducibility of brain ischemia in mice.

Authors:  Mutsuki Kuraoka; Takahisa Furuta; Takashi Matsuwaki; Tsutomu Omatsu; Yoshiyuki Ishii; Shigeru Kyuwa; Yasuhiro Yoshikawa
Journal:  Exp Anim       Date:  2009-01

Review 6.  Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

Authors:  Ronald Deumens; Arjan Blokland; Jos Prickaerts
Journal:  Exp Neurol       Date:  2002-06       Impact factor: 5.330

7.  Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits MMP-9-mediated blood-brain-barrier breakdown in a mouse model for ischemic stroke.

Authors:  Peter Ludewig; Jan Sedlacik; Mathias Gelderblom; Christian Bernreuther; Yücel Korkusuz; Christoph Wagener; Christian Gerloff; Jens Fiehler; Tim Magnus; Andrea Kristina Horst
Journal:  Circ Res       Date:  2013-06-18       Impact factor: 17.367

Review 8.  Disruption of the blood-brain barrier in Parkinson's disease: curse or route to a cure?

Authors:  Heyne Lee; Ilse S Pienaar
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

9.  Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke.

Authors:  Nancy L Monson; Sterling B Ortega; Sara J Ireland; Anouk Jm Meeuwissen; Ding Chen; Erik J Plautz; Erin Shubel; Xiangmei Kong; Min K Li; Laura H Freriks; Ann M Stowe
Journal:  J Neuroinflammation       Date:  2014-01-31       Impact factor: 8.322

10.  Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease.

Authors:  Justin Paul; Sidney Strickland; Jerry P Melchor
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

View more
  2 in total

Review 1.  Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair.

Authors:  Uma Maheswari Selvaraj; Katherine Poinsatte; Vanessa Torres; Sterling B Ortega; Ann M Stowe
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

2.  Spectrum effect correlation of yangyin tongnao granules on cerebral ischemia-reperfusion injury rats.

Authors:  Yangyang Zhang; Li Yu; Jiehong Yang; Zhishan Ding; Yu He; Haitong Wan
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.